---
title: "Edesa Biotech | 8-K: FY2026 Q2 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286467069.md"
datetime: "2026-05-14T20:53:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286467069.md)
  - [en](https://longbridge.com/en/news/286467069.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286467069.md)
---

# Edesa Biotech | 8-K: FY2026 Q2 Revenue: USD 0

Revenue: As of FY2026 Q2, the actual value is USD 0.

EPS: As of FY2026 Q2, the actual value is USD -0.49, missing the estimate of USD -0.26.

EBIT: As of FY2026 Q2, the actual value is USD -4.297 M.

The provided Form 8-K for Edesa Biotech, Inc. announces the issuance of a press release on May 14, 2026, detailing financial results for the three and six months ended March 31, 2026 . However, the actual financial results, operational metrics, or any forward-looking guidance are not included within the text of this Form 8-K itself . Therefore, no specific financial or operational metrics can be extracted from the provided reference .

### Related Stocks

- [EDSA.US](https://longbridge.com/en/quote/EDSA.US.md)

## Related News & Research

- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [Yext to Announce First Quarter Fiscal Year 2027 Financial Results on June 2, 2026 | YEXT Stock News](https://longbridge.com/en/news/286970613.md)
- [LOWE'S REPORTS FIRST QUARTER 2026 SALES AND EARNINGS RESULTS | LOW Stock News](https://longbridge.com/en/news/287043063.md)
- [OS Therapies to Announce First Quarter 2026 Financials on Monday, May 18, 2026 | OSTX Stock News](https://longbridge.com/en/news/286607728.md)